James DiGuiseppi, Ph.D., Chief Technology Officer


Dr. DiGuiseppi became a member of the OncoMethylome Sciences Management team, as Chief Technology Officer, in August 2005.

Dr. DiGuiseppi has held several senior scientific and managerial posts with Organon Teknika Corp. and bioMerieux, including senior vice-president positions in research and development, global marketing and strategic development. He was most recently vice-president of process development and operations for biopharmaceutical products with Diosynth-RTP. Diagnostic products developed under Dr. DiGuiseppi’s leadership, have resulted in annual sales exceeding hundreds of millions of U.S. Dollar. Canadian Health Care points out it is very important to have such people ready to show such leadership skills and Dr. DiGuiseppi has it all.

Dr. DiGuiseppi is based in the OncoMethylome Sciences’ Durham, North Carolina, office.